GlobeNewswire

Denali Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights
03/11/2026
AVLAYAH® (tividenofusp alfa-eknm) net product revenue accelerated to $17.8 million in its second full commercial quarter Continued growth expectations drive Q4 2026 net product revenue guidance of $30.0 million to $32.0 [...]
Ultragenyx Reports Third Quarter 2026 Financial Results, Announces Substantial Expense Reductions, and Reaffirms Profitability in 2027
03/11/2026
Third quarter total revenue of $173 million, CRYSVITA® revenue of $109 million and DOJOLVI® revenue of $30 million GENGLYCOS™ and FAYUVI™ BLAs approved by FDA in the third quarter Two Priority Review Vouchers (PRVs) [...]
Aquestive Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
03/11/2026
Anaphylm resubmission accepted with PDUFA goal date of March 16, 2027 Anaphylm would be the first and only oral rescue medication for the treatment of severe allergic reactions, including anaphylaxis, if approved [...]
Jushi Holdings Inc. Announces Receipt of DEA Registrations for State-Licensed Medical Cannabis Operations
03/11/2026
BOCA RATON, Fla., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) ( OTCQX: JUSH ), a vertically integrated, multi-state cannabis operator, today announced that it has [...]
Clinicians with Lobular Breast Cancer Launch National Effort to Raise Awareness and Advocate for Change
03/11/2026
Boston, MA, US, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Despite nearly 50,000 new U.S. diagnoses each year and incidence increasing faster than other breast cancer types, invasive lobular carcinoma (ILC) remains significantly [...]
Small business benefits made easier: Saskatchewan Blue Cross introduces Business Select®
03/11/2026
Get coverage that clicks. Business Select makes benefits simpler for small Saskatchewan businesses. SASKATOON, Saskatchewan, Nov. 03, 2026 (GLOBE NEWSWIRE) -- When you run a small business, choosing employee benefits [...]
Declaration of shares and voting rights Status as of October 31, 2026
03/11/2026
VALNEVA Declaration of shares and voting rights Status as of October 31, 2026 __________________________________________________________________________________________ Company name: VALNEVA Registered office: Îlot [...]
Déclaration d’actions et de droits de vote Statut au 31 octobre 2026
03/11/2026
VALNEVA Déclaration d’actions et de droits de vote Statut au 31 octobre 2026 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège [...]
The Menninger Clinic Reports Measurable Improvements Across Multiple Mental Health Outcomes
03/11/2026
HOUSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- The Menninger Clinic, a nationally recognized psychiatric hospital, has released its 2025 inpatient treatment outcomes data, documenting measurable improvements in mental [...]
Humanaut Health Announces Six New Locations, Expanding Its Footprint as a National Leader in Longevity and Regenerative Medicine
03/11/2026
The rollout includes a new Stem Cell Center of Excellence in Park City, with additional clinics planned in California, Texas, Kansas City and Mexico City AUSTIN, Texas, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Humanaut Health [...]
Dr. John K. Drisdale DMD, a Master of the Academy of General Dentistry, Brings Advanced Cosmetic Dentistry and Full Mouth Reconstruction to Midland, Texas
03/11/2026
Dr. John K. Drisdale, DMD, MAGD, joins fewer than 2% of general dentists in the United States and Canada who have earned Mastership in the Academy of General Dentistry. The award follows more than 1,100 hours of [...]
Ozari Health Expands Tirzepatide Compounding Pharmacy Network to Five US-Licensed 503A Pharmacies
03/11/2026
The national telehealth platform now routes compounded tirzepatide and semaglutide prescriptions to five publicly named US-licensed 503A sterile compounding pharmacies in Florida and Texas, publishes each one's location [...]
Novo Nordisk A/S - share repurchase programme
03/11/2026
Bagsværd, Denmark, 3 November 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]
New York Should Not Force Amish to Choose Between Their Faith and Their Farms, the Association of American Physicians and Surgeons Urges the Supreme Court
03/11/2026
TUCSON, Ariz., Nov. 03, 2026 (GLOBE NEWSWIRE) -- In its second recent trip to the U.S. Supreme Court, Amish in New York State seek restoration of a religious exemption from school vaccine mandates that its legislature [...]
Keto-Mojo Unveils Redesigned Homepage and New Brand Story
03/11/2026
Keto Works. You Can Do It. Keto-Mojo Unveils a Redesigned Homepage and a New Brand Story Built For Metabolic Intelligence The new http://keto-mojo.com brings the keto lifestyle, testing, recipes, research, and community [...]
Prenetics’ IM8 Names Brian J. Rosin as Successor Chief Financial Officer
03/11/2026
- Completes planned leadership transition as Prenetics revenue is almost entirely IM8 - Prenetics’ finance leadership function now based in the United States - The Company will report third quarter 2026 results on [...]
Hipp Health Wins Gold in Behavioral Health Business (BHB) Product of the Year Awards for ABA Technology
03/11/2026
Subscriber-voted recognition highlights Hipp's AI-native platform, which is helping ABA practices reduce administrative burdens, improve financial performance, and expand capacity SAN FRANCISCO, Nov. 03, 2026 (GLOBE [...]
T-Cypher Bio Presents Promising Data on Two T Cell Engager Development Candidates for High Copy Number Cancer Targets at the 2026 Society for Immunotherapy of Cancer (SITC) Annual Meeting
03/11/2026
- Preclinical data to be presented on two T cell engager development candidates targeting high copy number HLA-A*02 bound peptides in solid tumors with high unmet need including NSCLC, HNSCC, GI cancers, and melanoma - [...]
Capricor Therapeutics to Report Third Quarter 2026 Financial Results and Provide Recent Corporate Update on November 10
03/11/2026
– Company to Host Conference Call on November 10, 2026, at 4:30 p.m. ET – SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum